We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Deep Learning–Based Method Improves Cancer Diagnosis

By LabMedica International staff writers
Posted on 12 Jan 2026

Identifying vascular invasion is critical for determining how aggressive a cancer is, yet doing so reliably can be difficult using standard pathology workflows. More...

Conventional methods require multiple chemical stains to be applied to separate tissue sections, which increases cost, processing time, and the risk of losing diagnostic information. Researchers have now developed an artificial intelligence (AI)-based approach that can digitally generate multiple diagnostic stains from a single unstained tissue section, enabling more accurate assessment of cancer invasion.

Researchers at the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), in collaboration with Hadassah Hebrew University Medical Center (Jerusalem, Israel) and the University of Southern California (USC, Los Angeles, CA, USA), have introduced a virtual multiplexed immunohistochemistry framework that converts autofluorescence microscopy images of label-free tissue into brightfield-equivalent images of hematoxylin and eosin staining, along with two key immunohistochemical markers: ERG for endothelial cells and PanCK for epithelial tumor cells.

Unstained tissue sections were first imaged using autofluorescence microscopy. A conditional generative adversarial network then digitally transformed these images into multiple virtual stains using a single deep neural network. A digital staining matrix guided the model to produce precisely aligned virtual H&E, ERG, and PanCK images from the same tissue section, eliminating the need for serial sectioning and chemical staining.

When applied to thyroid tissue microarrays, the virtual staining approach showed high concordance with conventional histochemical and immunohistochemical stains. In blinded evaluations, board-certified pathologists found that the digitally generated stains were comparable to traditional methods and, in some cases, demonstrated improved consistency and specificity. The approach, presented in BME Frontiers, enabled clearer visualization of tumor cells within blood or lymphatic vessels, supporting more reliable identification of vascular invasion.

Because the staining is generated computationally, the method avoids many artifacts associated with conventional immunohistochemistry and delivers highly reproducible results. Virtual stains can be produced within seconds for individual regions and in minutes for whole-slide images, making the framework compatible with high-throughput digital pathology workflows. While demonstrated in thyroid cancer, the approach could be extended to other tumor types and additional diagnostic markers, pending further multi-center clinical validation.

Related Links:
UCLA
Hadassah Hebrew University Medical Center
USC


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New findings demonstrate a blood RNA signal that may indicate ovarian cancer before conventional tests detect a tumor. (Image Credit: iStock)

Blood RNA Test May Detect Precursors to Ovarian Cancer

High-grade serous ovarian cancer is often diagnosed at an advanced stage, limiting opportunities for early intervention. The disease frequently originates in the fallopian tube as serous tubal intraepithelial... Read more

Hematology

view channel
Image: These new ANC reference ranges can help clinicians more accurately interpret neutrophil counts, reduce unnecessary testing and treatment interruptions, and help support more equitable care. (Photo courtesy of the American Society of Hematology)

New Reference Ranges Clarify Normal Neutrophil Counts in Duffy-Null Patients

Duffy-null status is a common genetic trait associated with naturally lower circulating white blood cell counts. It affects about 10% of the U.S. population and more than 66% of people with African or... Read more

Immunology

view channel
Image: The panel expands Cepheid’s respiratory testing portfolio on the GeneXpert platform, offering laboratories greater flexibility in selecting tests based on clinical needs. (Photo courtesy of Cepheid)

Multiplex PCR Test Gains CE Marking to Support Respiratory Infection Diagnosis

Acute respiratory infections often present with overlapping symptoms, making it difficult to distinguish between viral and bacterial causes. Seasonal surges of influenza-like illness in Europe further... Read more

Microbiology

view channel
Image: VITEK PRO combines microbial identification and antimicrobial susceptibility testing on a single platform to support routine microbiology workflows and antibiotic selection. (Photo courtesy of bioMérieux)

Automated Microbial Identification and Susceptibility System Gains FDA Clearance

Antimicrobial resistance (AMR) is a leading global public health threat, causing an estimated 1.27 million deaths annually. The growing challenge of diagnosing and treating resistant infections highlights... Read more

Industry

view channel
Image: The collaboration aims to expand access to the technology through a regulated clinical diagnostics pathway in Japan.

Partnership Aims to Bring Blood-Based Alzheimer’s Testing to Japan

Alzheimer’s disease remains a growing diagnostic challenge as populations age and cognitive impairment becomes more common. In Japan, government-supported estimates project that approximately 4.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.